MI-RICARDO
14.7.2022 13:54:07 CEST | Business Wire | Press release
The United States Army has awarded Ricardo’s Defense business unit, located in Michigan, over 18.9million USD to deliver additional Antilock Brake System/Electronic Stability Control (ABS/ESC) retrofit kits to improve the safety of operation of the US Army’s High Mobility Multipurpose Wheeled Vehicle (HMMWV).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005571/en/
In addition to those retrofit kits Ricardo has previously delivered, this contract award will improve safety on fielded vehicles in the US Army’s enduring HMMWV fleet. Additionally, more than 7,000 new production or recapitalized HMMWV vehicles have been delivered to the US Army with Ricardo’s integrated ABS/ESC technology following the Army’s mandate of the Ricardo system on all new production HMMWVs. In 2019, the Army provisioned Ricardo’s ABS/ESC retrofit kit into the national stock system for application of vehicles produced prior to 2019 that are slated to remain in the Army’s enduring fleet through 2040.
Chet Gryczan, President of Ricardo Defense said: “Ricardo is committed to providing our customers with mission critical, innovative, integrated solutions that deliver capability to the soldier. This award demonstrates that Ricardo can solve tough challenges for legacy systems that require a future-looking integrated solution. Consistent with our core values of sustainable, safe, and smart mobility, the successful deployment of Ricardo’s ABS/ESC safety critical system ensures the safety of soldiers and operators remain at the forefront of every training and operational mission. We are extremely proud to support the US Army’s objective ensuring that soldier safety remains a top priority throughout each mission.”
The Ricardo developed ABS/ESC retrofit system encompasses a complete solution integrated into the HMMWV architecture including antilock braking, electronic stability control, active rollover protection, traction control, and improved brake calipers, pads, and rotors. The Ricardo system additionally introduces a crashworthy steering column and a modern electronic network to the vehicle and leverages low-cost, proven components specifically designed for the arduous requirements of military application. From the beginning, Ricardo designed the system for ease of upgrade to the existing fleet to minimize HMMWV lifecycle cost to US taxpayers.
Ends
Ricardo Defense Inc, is the business entity within Ricardo plc that works on classified safety and defence contracts for the US DoD and it therefore operates as a separate entity governed by a Special Security Agreement (SSA). Ricardo Defense Inc provides solutions to meet the challenges faced by defence customers in the integration of complex and diverse systems specialising in taking innovative technologies from science to real-world deployment.
About Ricardo
Ricardo plc is a global strategic, environmental, and engineering consulting company, listed on the London Stock Exchange. With over 100 years of engineering excellence and employing close to 3,000 employees in more than 20 countries, we provide exceptional levels of expertise in delivering leading-edge and innovative cross-sector sustainable products and solutions. Every day, we enable our customers to solve the most complex and dynamic challenges to help achieve a safe and sustainable world. Visit www.ricardo.com
Ricardo Defense Inc, is the business entity within Ricardo plc that works on classified safety and defence contracts for the US DoD and it therefore operates as a separate entity governed by a Special Security Agreement (SSA). Ricardo Defense Inc provides solutions to meet the challenges faced by defence customers in the integration of complex and diverse systems specialising in taking innovative technologies from science to real-world deployment.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220629005571/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom